|
A.S.Ametov
Type 2 Diabetes Mellitus And Non-alcoholic Fatty Liver Disease: Guidelines For Endocrinologists
|
№5 / 2013
|
|
E.E.Arinina, M.A.Rasheed, M. B. Antsiferov
Pharmacoeconomic Analysis Of Advantages Of Combined Incretin Therapy In Patients With Type 2 Diabetes Mellitus By The Example Of Vildagliptin
|
№5 / 2013
|
|
A.F.Verbovoy, L.A.Sharonova, N.I.Verbovaya, D. V. Demidova, A.V.Kapishnikov
The Levels Of Vitamin D3 And Parameters Of Bone Metabolism In Women With Type 2 Diabetes Mellitus
|
№5 / 2013
|
|
M. B. Antsiferov, G. Schernthaner, A.S.Ametov
Innovative Hypoglycemic Therapy: A New Strategy For An Old Problem
|
№5 / 2013
|
|
L.A.Ruyatkina, A.V.Lomova, D. S. Ruyatkin
Bone Status In Type 2 Diabetes Mellitus
|
№5 / 2013
|
|
E.V. Biryukova
Rational Choice Of Pharmacotherapy In Type 2 Diabetes Mellitus
|
№5 / 2013
|
|
L.A.Ruyatkina 1, M.Yu.Sorokin 2
Choice Of Gliptins In Different Clinical Situations – Comments To Patient Portraitscentral Tibetian Medical Paintings.
|
№20 / 2012
|
|
M.B. Antsiferov, L.G. Dorofeyeva
Experience In The Use Of A New Form Of Gliclazide Mr 60 Mg (diabeton Mr 60 Mg) In The Treatment Of Patients With Type 2 Diabetes Mellitus
|
№16 / 2012
|
|
M.B. Antsiferov 1, G.R. Galstyan 2
Administration Of Antidiabetic Drug To Patients – What Is Necessary, Except Prescription?
|
№16 / 2012
|
|
A.S. Ametov, MD, Professor; A.V. Braschenkova
Rational Pharmacotherapy Of Type 2 Diabetes Mellitus: Use Of Dpp-4 Inhibitor Saxagliptin And Metformin In Clinical Practice
|
№16 / 2012
|
|
A.M. Shilov, A.G. Abdullayeva
Features Of Treatment Of Glucose Intolerance In Patients With Abdominal-visceral Obesity At Early Stages Of Its Development
|
№11 / 2012
|
|
A.Yu.Mayorov
Algorithms Of Specialized Medical Care For Diabetic Patients 2011: Major Changes
|
№11 / 2012
|
Русский
